NCT01552590View on ClinicalTrials.gov

Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites

PHASE4TerminatedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Hyponatremia and Extracellular Fluid in Cirrhotic
Interventions
DRUG

Tolvaptan

DRUG

Placebo

Trial Locations (3)

Unknown

Hallym Univ. Chuncheon Sacred Heart Hospital, Bucheon-si

Soonchunhyang Univ. Bucheon Hospital, Bucheon-si

Wonju Christian Hospital, Wŏnju

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY